What's Holding Cell Therapies Back? A Look Into The Evolution And ...
Stem Cells News - ScienceDaily
17, 2024 — Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem ...
Unique complexities in cell therapy manufacturing - AstraZeneca
Cell therapies are currently in development with the aim to halt and reverse disease, restore damaged organs, and ultimately, cure many life- ...
New therapies won't happen without people trained to work with stem cells who have both the technical skills and the equipment they need. We have funded ...
CAR T therapies in multiple myeloma: unleashing the future - Nature
This novel treatment method complements options like autologous stem cell transplants and immunomodulatory medications, such as proteasome ...
Bringing stem cells to patients: Treating age-related blindness
Learn about the ongoing stem cell-based clinical trials to treat the most common form of age-related blindness, macular degeneration.
About Stem Cells | A resource empowering patients & the public.
Stem cells hold potential for treating a wide range of diseases and conditions, and stem cell research has led to new discoveries that can improve human health.
Gene and Cell Therapy Institute | Mass General Brigham
What are gene and cell therapies? ... Gene and cell therapies are advanced medical treatments aimed at stopping or slowing disease progression. Gene therapy ...
Stem cell therapy for Parkinson's: Are we getting closer?
Stem cells hold promise for slowing, or even reversing, the progression of Parkinson's. For more than a decade, researchers have worked to ...
Researchers are also looking into the role that certain stem cells might play in helping drugmakers test the safety and effectiveness of ...
Secondary Cancers Following CAR T Cell Therapy Are Rare
CAR T cell therapy, a personalized form of immunotherapy in which each patient's T cells are modified to target and kill their cancer cells, was ...
09 Delivering Efficiency and Quality to Cell Therapy Manufacturing
Cell and Gene Therapy (CGT) is an exciting branch of medicine that is focused on regrowth, repair and replacement of damaged cells or tissues. The market in ...
Regenerative Medicine: A New Path for ALS Treatment - Cedars-Sinai
Their goal: to test the safety of a combination stem cell/gene therapy to treat the rare neurodegenerative disease, caused by the unexplained, ...
Upstream stem cell therapy process development | Cytiva
A major challenge for cell-based therapies is scale-up, that is, producing enough cells to meet the preclinical or clinical dose requirements. With T cell ...
New Strategy for Preventing Relapse After CAR T-Cell Therapy
The platform also prompts CAR T cells to form a memory of the cancer cells so they can spring back into action if the cancer recurs. Get more ...
Understanding Stem Cell Research | UCLA BSCRC
The embryonic stem cells are isolated from the inner cell mass of the blastocyst, a stage in early human embryonic development that occurs within the first four ...
Considerations for the development of iPSC-derived cell therapies
Since their first production in 2007, human induced pluripotent stem cells (iPSCs) have provided a novel platform for the development of various cell ...
Gene and Cell Therapies Hold Potential—but How Can Payers ...
Cell therapy refers to the manipulation of cells that are then infused back into the body with the capacity to target and diminish other ...
National Strategy for Gene and Cell Therapies presented to the ...
Gene and cell therapies (GCTs) are some of the key technologies driving innovation in biomedical research and patient care. They are not only ...
McKinsey insights on cell and gene therapy | Life Sciences
Browse our collection of articles for an in-depth look at the opportunities ... What will the next decade hold for these life-changing therapies? Gene ...
TrakCel: Cell And Gene Therapy Orchestration Solutions
Unrivaled understanding and experience of the cell and gene therapy industry, cellular orchestration and emerging therapies in both the clinical trial and ...